Navigation Links
Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
Date:7/8/2009

CAMBRIDGE (UK). 8th July 2009 / b3c newswire / - Funxional Therapeutics Ltd (Funxional) has announced today the successful completion of the first Phase I study with FX125L, an orally available small molecule which belongs to a new therapeutic class named Broad Spectrum Chemokine Inhibitors (BSCIs).

The Phase I, single ascending dose study was conducted in the United States. FX125L was well tolerated at all doses studied and no serious adverse events or subject withdrawals were observed. The pharmacokinetics of FX125L was linear over the wide dose range studied and consistent with once-daily oral dosing for patients.

We are extremely pleased with the outcome of this initial clinical study with FX125L said Konstantinos Efthymiopoulos, CEO of Funxional Therapeutics. The results in humans are consistent with the preclinical data, suggesting that FX125L has a very wide safety margin, and confirmed the excellent drug-like profile of FX125L.


About Funxional Therapeutics Ltd.
Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK) which focuses on novel anti-inflammatory therapies. FXT is managed by a very experienced team and is financed by Index Ventures and Novo A/S, while its shareholders also include Ipsen and Cambridge University. FXT has research and office facilities in Cambridge.
For more information about FXT, please visit our web site (www.funxionaltherapeutics.com) or contact us by e-mail ( info@funxionaltherapeutics.com ).

About BSCIs

BSCIs are anti-inflammatory compounds with an entirely novel mechanism of action that involves the selective interaction with a well-characterized receptor, resulting in a potent in
'/>"/>

b3c newswire

0

GOOD

Page: 1 2

Related biology news :

1. In troubled economic times, BioSquare 2009 successfully serves as business and innovation starter
2. Salk researchers successfully reprogram keratinocytes attached to a single hair
3. Model successfully predicts large river system fish diversity
4. Scientists successfully treat new mouse model of inflammatory bowel disease
5. Researchers successfully simulate photosynthesis and design a better leaf
6. MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR
7. A new milestone in the GMES Space Component Program successfully achieved
8. Life on Mars pregnancy test successfully launched
9. DOE Joint Genome Institute completes soybean genome
10. L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
11. bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...registration rates and register online now for the.../www.iofwco-ecceo10.org/ , WHAT: IOF WCO-ECCEO...orosis Foundation (IOF) and the European Society f...nd Osteoarthritis (ESCEO). More than 5,000 partici.... The exciting scientific programme includes 12 pl...
(Date:11/30/2009)...eeing your extended family over the holidays was s...n the December 2009 print issue of the Journal of...ows that you might be right. Here,s the good news:...y new treatments that help keep autoimmune disease... That,s because researchers from the University of...
(Date:11/30/2009)..., Nov. 30 Neurotechnology ( http:/...cision biometric identification technologies, has ...oduct line: VeriLook 4.0 Software Development Ki....1 SDK for large-scale multi-biometric and automat...nded capabilities in VeriLook 4.0 provide enhanced...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Martin Hensen head of e strategies UCB Germany 3A Making e marketing more than just an add on 9458 1Five Questions About Protopic 28tacrolimus 29 Ointment 13332 1Five Questions About Protopic 28tacrolimus 29 Ointment 13332 2Five Questions About Protopic 28tacrolimus 29 Ointment 13332 3Five Questions About Protopic 28tacrolimus 29 Ointment 13332 4Synthetic biology opportunities and risks 53488 1Synthetic biology opportunities and risks 53488 2Synthetic biology opportunities and risks 53488 3
...lcome Fund has announced the recipients of the 200...Disease awards. , The Investigators in the Pathog...0 during a five-year period to encourage aggressiv...athogenesis. BWF launched the program in 2002 and... $30 million in the careers of investigators who a...
... has developed a new water treatment that could he.... , David Hand, a professor of civil and environm...simple way to treat ballast water in vessels rangi... designed to kill the virus that causes viral hemo...hat has been attacking fish populations in the low...
...the 2008 Environmental Scientists of the Year by T...rother, biologist Jules Blais, is the other winner...tigious in the environmental sciences. The prize r...ic work to Canadian society. , Smol is series ed...aleoenvironmental Research and has also edited man...
Other Biology News:BWF awards $7 million to infectious disease investigators 2New ballast treatment could protect Great Lakes fish 2
(Date:11/29/2009)...ailable in German . , The concept of confin...s. The most famous example is that of quarks which...rof. Bella Lake from Helmholtz-Zentrum Berlin toge...rt for the first time an experimental realization ...a condensed matter system. , The concept of conf...
(Date:11/27/2009)..., November 27 Stallergen...alair(R) in both adults and children,through a Mut...try where,Oralair(R) has been marketed, was the re... registered in Austria, Belgium, Bulgaria, Cyprus,...ece, Hungary, Ireland, Italy,Latvia, Lithuania, L...
(Date:11/25/2009)...HAM, N.C., Nov. 25 Research Triang...y-efficient, single-treatment water purification s... to Andhra Pradesh, Minister of Rural Water Supply...rabad, India today. Initial tests, performed at In...ed that the majority of the drinking water availab...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. 25 /PRNews...ful year. Not so for BodyLogicMD. The nation,s la...ians specializing exclusively in medically supervi...of physicians in its network since November ...ess to add more physician-owned centers, including...
Breaking Biology Technology:Spinons -- confined like quarks 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4
...ction July 27, 2008 Completes Enrollment for VEC... Md., Feb. 14 Vanda Pharmaceuticals,Inc. (Nasdaq:...he development,and commercialization of clinical-s... disorders, today announced financial and operatio... ended December 31, 2007., Vanda reported researc...
...nch; Positioned for Expanded Growth in ...th Quarter and 2007 Financial Highlights:, * Soli...illion in Q4 2007, compared to net product sale...s was $12.3 million, or $0.33 per share, compared ...er share, in Q3 2007., * Q4 non-GAAP net loss was...
...nced,today that the Chicago Athenaeum Museum of Ar...GN(TM) Award for the new SoloSTAR(R) disposable,in...e 2 diabetes., "LANTUS(R) SoloSTAR(R) and APIDRA(...intensive development, have been designed in dialo... high standards of the industry,",said Paul Jansen...
Other Biology Technology:Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 4Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 5Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 6Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 7Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 8Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 9Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 10Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 11Alexion Reports Fourth Quarter and Full Year 2007 Results 2Alexion Reports Fourth Quarter and Full Year 2007 Results 3Alexion Reports Fourth Quarter and Full Year 2007 Results 4Alexion Reports Fourth Quarter and Full Year 2007 Results 5Alexion Reports Fourth Quarter and Full Year 2007 Results 6Alexion Reports Fourth Quarter and Full Year 2007 Results 7Alexion Reports Fourth Quarter and Full Year 2007 Results 8Alexion Reports Fourth Quarter and Full Year 2007 Results 9Alexion Reports Fourth Quarter and Full Year 2007 Results 10Alexion Reports Fourth Quarter and Full Year 2007 Results 11Alexion Reports Fourth Quarter and Full Year 2007 Results 12Alexion Reports Fourth Quarter and Full Year 2007 Results 13Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 2Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 3Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 4Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award 5
EZ-Retriever System from BioGenex
...00 drug discovery system miniaturizes, integrates ...ing LabChip technology, the LabChip 3000 performs ... fashion. LabChip assays are separations-based, so... in homogenous, well-based assays. No other screen...
Fluorogenic Chip, 4-Sipper from Caliper Life Sciences
...ystem, 100-120 and 220-240 V, is a microfluidics-b...ed electrophoresis, including some data analysis, ...or protein analysis (it does not include the vorte...ncludes the electrophoresis station, priming stati...
Biology Products: